...
首页> 外文期刊>Medicinal chemistry research: an international journal for rapid communications on design and mechanisms of action of biologically active agents >Novel adefovir mono L-amino acid ester, mono bile acid ester derivatives: Design, synthesis, biological evaluation, and molecular docking study
【24h】

Novel adefovir mono L-amino acid ester, mono bile acid ester derivatives: Design, synthesis, biological evaluation, and molecular docking study

机译:新型Adefovir Mono L-氨基酸酯,单胆汁酸酯衍生物:设计,合成,生物学评价和分子对接研究

获取原文
获取原文并翻译 | 示例

摘要

A series of adefovir mono L-amino acid ester, mono bile acid ester derivatives was designed and synthesized. The newly designed compounds have potent anti-anti-hepatitis B activity, especially compound 6c, which has more potent antiviral activity and a higher selectivity index (EC50 0.65 mu mol/L, SI 582.24) than adefovir dipivoxil. Uptake of compounds 6a-f into rat primary hepatocytes was 71.56, 63.92, 142.88, 104.25, 67.84, and 39.95-fold, respectively, higher than that of adefovir dipivoxil. In the presence of Na+, uptake of compounds 6a-c by Na+/taurocholate co-transporting polypeptide-Human embryonic kidney 293 cells was 128.5, 137.2 and 121.7-fold higher than that of adefovir dipivoxil. Potential binding modes of compounds 6a and 6c to human apical Na+-dependent bile acid transporter were also investigated.
机译:一系列AdeFovir Mono L-氨基酸酯,设计和合成了单胆汁酸酯衍生物。 新设计的化合物具有有效的抗抗丙型肝炎活性,特别是化合物6c,其具有比Adefovir DipivoOvoOvir DipivoOxil更有效的抗病毒活性和更高的选择性指数和更高的选择性指数(EC50 0.65My mol / L,Si 582.24)。 将化合物6A-F的摄取分别为71.56,63.92,142.88,104.25,67.84和39.95倍,高于Adefovir Dipivoxil的39.95倍。 在Na +存在下,通过Na + /牛磺酸盐的化合物6a-c的摄取共同转移多肽 - 人胚胎肾293细胞的摄取为128.5,137.2和121.7倍,高于Adefovir Dipivoxil。 还研究了化合物6a和6c至人顶酰亚+依赖性胆汁酸转运蛋白的潜在结合模式。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号